摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tert-butyl N-[1-[4-(4-oxo-3-phenylquinazolin-2-yl)phenyl]cyclobutyl]carbamate | 1357159-35-3

中文名称
——
中文别名
——
英文名称
tert-butyl N-[1-[4-(4-oxo-3-phenylquinazolin-2-yl)phenyl]cyclobutyl]carbamate
英文别名
——
tert-butyl N-[1-[4-(4-oxo-3-phenylquinazolin-2-yl)phenyl]cyclobutyl]carbamate化学式
CAS
1357159-35-3
化学式
C29H29N3O3
mdl
——
分子量
467.568
InChiKey
ORBKNTAUSIVXAK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.96
  • 重原子数:
    35.0
  • 可旋转键数:
    4.0
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.28
  • 拓扑面积:
    73.22
  • 氢给体数:
    1.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    tert-butyl N-[1-[4-(4-oxo-3-phenylquinazolin-2-yl)phenyl]cyclobutyl]carbamate盐酸 作用下, 以 1,4-二氧六环 为溶剂, 反应 4.0h, 以68%的产率得到2-[4-(1-aminocyclobutyl)phenyl]-3-phenylquinazolin-4-one hydrochloride
    参考文献:
    名称:
    Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT
    摘要:
    Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.
    DOI:
    10.1021/jm201394e
  • 作为产物:
    描述:
    tert-butyl 1-(4-formylphenyl)cyclobutylcarbamate2’-氨基苯甲酰苯胺对甲苯磺酸2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 1,4-二氧六环 为溶剂, 反应 17.0h, 以73%的产率得到tert-butyl N-[1-[4-(4-oxo-3-phenylquinazolin-2-yl)phenyl]cyclobutyl]carbamate
    参考文献:
    名称:
    Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT
    摘要:
    Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.
    DOI:
    10.1021/jm201394e
点击查看最新优质反应信息